Chronic Obstructive Pulmonary Disease (COPD) by Trimmer, Jenna
Otterbein University 
Digital Commons @ Otterbein 
Nursing Student Class Projects (Formerly MSN) Student Research & Creative Work 
8-2-2017 
Chronic Obstructive Pulmonary Disease (COPD) 
Jenna Trimmer 
jenna.blauser@otterbein.edu 
Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn 
 Part of the Nursing Commons 
Recommended Citation 
Trimmer, Jenna, "Chronic Obstructive Pulmonary Disease (COPD)" (2017). Nursing Student Class Projects 
(Formerly MSN). 216. 
https://digitalcommons.otterbein.edu/stu_msn/216 
This Project is brought to you for free and open access by the Student Research & Creative Work at Digital 
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an 
authorized administrator of Digital Commons @ Otterbein. For more information, please contact 
digitalcommons07@otterbein.edu. 
Chronic	Obstructive	Pulmonary	DiseaseJenna	Trimmer,	RN,	BSN
Introduction
The	overall	incidence	of	chronic	obstructive	pulmonary	disease	(COPD)	is	increasing	and	negatively	affecting	the	quality	of	life	of	the	patient.			Chronic	obstructive	pulmonary	disease	is	associated	with	a	high	morbidity	and	mortality	rate	and	is	currently	the	4thleading	cause	of	death	in	the	United	States	and	is	projected	to	be	the	3rd by	2020	(Schnell,	K.,	et	al.,	2012).Due	to	the	high	incidence	and	chronicity	of	COPD,	patients	frequently	present	for	treatment	,	often	face	hospital	admissions	related	to	acute	exacerbations,	and	require	life-long	treatment	for	disease	management	(Han,	Dransfield,	&	Martinez,	2017).		Because	of	this,	the	family	nurse	practitioner	(FNP)	will	without	a	doubt	encounter	and	provide	treatment	for	a	patient	with	COPD.This	is	further	supported	by	Yawn,	Wollan,	Trextor,	and	Yawn	(2016)	who	state	COPD	is	common	and	most	patients	diagnosed	with	COPD	receive	care	from	their	primary	care	providers	and	most	recently	from	nurse	practitioners	and	physician’s	assistants.		Due	to	the	prevalence	of	COPD	and	those	presenting	for	treatment,	the	FNP	will	need	to	have	an	understanding	of	the	disease	process	to	better	serve	the	patient.		Rennard	et	al.		(2013)	states	COPD	is	said	to	be	unappreciated	with	half	of	the	COPD	patients	being	undiagnosed	or	undertreated.		
Pathophysiology
What	is	COPD
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Signs	and	Symptoms	of	COPD
Chronic	obstructive	pulmonary	disease	is	said	to	be	a	preventable	and	treatable	disease;	not	reversible	(Halldin,	Doney,	&	Hnizdo,	2015).A	description	of	COPD	is	provided	by	the	Centers	for	Disease	Control	and	Prevention	(CDC)	as	a	group	of	lung	diseases	which	causes	a	progressive	blockage	of	expiratory	air	flow.		The	subtypes	of	COPD	is	inclusive	of:	asthma,	chronic	bronchitis,	and	emphysema.		
Asthma
• A	variable	inflammation	of	the	airways	with	hypersecretion	of	mucous	and	bronchial	constriction	causing	airflow	obstruction.		
• Exposure	to	irritants	is	the	primary	trigger	of	asthma	and	avoidance	of	these	irritants	is	key.
• Large	familial	incidence	of	asthma.
• IgE	is	thought	to	be	a	contributor	to	the	pathophysiologic	characteristics	of	asthma.
• Exposure	to	antigens	cause	epithelial	damage,	basement	membrane	thickening,	and	eosinophil	infiltrates	into	the	walls	of	the	airways.
• There	is	an	influx	of	neutrophils,	eosinophils,	mast	cells,	and	tumor	necrosis	factor- alpha.
• Inflammatory	and	pro-inflammatory	mediators	cause	epithelial	damage,	mucous	plugging,	and	increased	endothelial	permeability	causing	airway	edema.	(Lugogo	&	MacIntyre,	2008).
• The	presence	of	CD4+	T-lymphocytes,	eosinophils,	and	increased	interleukin	(IL)-4	and	IL5	is	characteristic	of	the	bronchial	inflammation	seen	in	asthma	(Han,	Dransfield,	&	Martinez,	2017).	
• The	individual	signs	and	symptoms	of	asthma	are:	sporadic	chest	tightness,	cough,	wheezing,	and	shortness	of	breath	with	fluctuating	and	reversible	airflow	obstruction;	not	all	wheezing	is	asthma	and	not	all	asthma	wheezes	(Halldin,	Doney,	&	Hnizdo,	2015).
Chronic	Bronchitis
• The	pathophysiologic	process	of	bronchitis	is	triggered	by	irritants	which	cause	airway	inflammation;	the	largest	contributing	factor	being	cigarette	smoke.		
• Inflammation	and	thickening	of	the	bronchial	tubes	with	a	hypersecretion	of	mucus.
• There	is	an	overproduction	of	mucous	due	to an	increased	amount	and	size	of	goblet	cells	and	enlarged	submucosal	glands.	
• The	individual	signs	and	symptoms	of	bronchitis	are:	activity	intolerance	,	shortness	of	breath,	and	chronic	cough	lasing	for	a	minimum	of	three	months	in	two	consecutive	years.	(Han,	Dransfield,	&	Martinez,	2017).
Emphysema
• Destruction	of	structures	distal	to	the	terminal	bronchial	which	include	the	respiratory	bronchial,	alveolar	ducts,	sacs,	and	alveoli;	collectively	the	acinus.
• Abnormal,	irreversible	enlargement	of	the	terminal	airspaces	which	accompanies	destruction	of	the	alveolar	walls.		The	elasticity	of	the	lung	is	lost	resulting	in	airflow	obstruction.	
• The	individual	signs	and	symptoms	of	emphysema	are:	weight	loss- thought	to	be	due	to	the	increased	metabolic	demands	of	breathing	with	use	of	accessory	muscles,	shortness	of	breath	with	activity	eventually	advancing	to	shortness	of	breath	while	at	rest,	non-productive	cough,	and	a	prolonged	period	of	expiration.(Han,	Dransfield,	&	Martinez,	2017).
• Major	contributing	factor	of	the	development	of	emphysema	is	cigarette	smoke.		
• Genetic	risk	factor	identified	in	emphysema:	Alpha	1-antitriypsin	(ATT)	deficiency.			(Bauldoff,	2012).
Significance	of	Pathophysiology	
and	Its	Implications	for	
Nursing	CareFor	the	ANP	to	know	the	manifestations	and	progression	of	COPD,	there	needs	to	first	be	an	understanding	of	its	pathophysiology	to	guide	the	correct	diagnosis	and	appropriate	treatment	to	prevent	disease	progression	and	complications.
• Provide	risk	reduction	education:	- Smoking	cessation	and	avoidance	of	other	irritant	exposures- Vaccines	against	respiratory	infections- Appropriate	nutrition- Medication	compliance	and	proper	use- Self	care	and	symptom	management(Garvey,	2011).
• For	all	COPD	patients,	short	acting	beta	agonists	and/or	anticholinergic	bronchodilator	use	is	recommended	to	improve	symptoms	and	lung	function
• Long	acting	beta	agonists	are	used	for	more	symptomatic	patients(Ferguson,	2017).	The	management	of	COPD	is	difficult.		The	advanced	nurse	practitioner	(ANP)	will	need	to	maximize	each	patient	visit	to	provide	education	of	proper	medication	compliance	and	inhaler	use	while	assisting	and	providing	education	where	needed.		The	nurse	will	be	involved	in	the	diagnosis	of	COPD	by	performing	spirometry	and	testing;	patient	education	is	key	to	obtaining	accurate	results.Since	smoking	is	the	major	contributing	factor,	smoking	cessation	and	support	is	an	integral	part	of	care.Exacerbations	are	common	and	the	patient	will	need	to	be	educated	of	the	signs	and	symptoms	and	when	to	present	for	treatment	to	avoid	a	hospital	admission.Exercise	and	nutrition	should	be	included	in	the	care	of	the	COPD	patient.	Obesity	will	increase	the	work	load	of	the	patient	while	those	who	are	underweight	have	shown	to	have	a	poor	prognosis.Anxiety	and	depression	are	common,	the	APN	will	need	to	provide	support	and	education	to	the	patient	and	family.		
Most	patients	with	COPD	will	be	diagnosed	and	treated	in	the	primary	care	setting.		As	nursing	accounts	for	the	largest	segment	of	the	healthcare	workforce,	APNs	have	a	key	role	in	the	diagnosis	and	management	of	the	patient	with	COPD.		Because	COPD	is	a	chronic	disease	requiring	life-long	treatment,	patient	education	and	compliance	is	a	large	factor	of	that	treatment.		The	APN	will	need	to	help	guide	and	support	their	patient	in	taking	responsibility	for	their	care.
Conclusion
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The	changes	associated	with	COPD	are	primarily	seen	in	the	airways,	lungs,	and	pulmonary	vasculature.		The	changes	and	their	pathologic	processes	are	dependent	upon	the	underlying	disease,	susceptibility	to,	and	severity	of	the	disease.		Collectively,	the	signs	and	symptoms	of	COPD	include:	dyspnea,	activity	intolerance,	chronic	productive	or	non-productive	cough,	wheezing,	and	chest	tightness.Gradual	onset	of	the	symptoms	tend	to	contribute	to	the	underdiagnosis	of	COPD	as	these	symptoms	are	often	common	in	presentation	of	other	diseases.
(Han,	Dransfield,	&	Martinez,	2017).
Risk	Factors	for	COPD
• Cigarette	smoking	and	second	hand	exposure	to	cigarette	smoke.- The	most	significant	factor	of	the	development	and	progression	of	COPD.
• Air	pollution
• Reduced	lung	development	or	frequent	and	severe	lung	infections	during	childhood.
• History	of	asthma
• Lower	socioeconomic	status
• Poor	nutrition
• Genetic	risk	factor	of	ATT	deficiency
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